MONOLITH in Everyone's Eyes — Striving to Be a Honey Badger
Transparent, sincere, truth-seeking
Articles
FengRui 2025 Year-End Review: Staying True to First Principles, Resiliently Navigating Cycles
Vibe Coding, Act Two: The Big Four, and Those Who Want to Win | A Conversation with Guangxiang Zhu, Baidu Miaoda Product GM
He built a wheel — and ran it over the 20-year-old version of himself.
Qiming Venture Partners | Global Top Biotech VCs Gather, First S2S China Symposium Startup Proposal Countdown Begins
Top scientists are invited to visit the S2SChina website and submit proposals, embarking on an accelerated journey from the lab to entrepreneurship.
Yunqi Capital | Noematrix Closes Series A Funding Round
R&D iteration and commercial deployment are accelerating.
Yunqi Capital Research | Embodied Intelligence in Industrial Scenarios: In-Depth Analysis of Capabilities and Applications
Full Throttle · Yunqi Capital New Year Goods Collection Vol. 1
New Forces Keep Coming｜5Y News Monthly
The big news from last month.
A Deep-Dive Observation of FLAME's First Discharge: A Conversation with Starlight Fusion | PORTFOLIO
Another path to igniting fusion energy.
CasCade Therapeutics Closes Nearly 500 Million Yuan Major Funding Round, Targeting Nuclear Receptor and GPCR Innovative Drug R&D
Dedicated to becoming a global leader in metabolic disease therapeutics.
Qiming Venture Partners' Alex Zhou: AXERA's "Chip and AI" Expertise and Platform Strategy Built Its Success
Qiming Venture Partners has landed its third AI-related IPO in less than 40 days since the start of 2026.